|Bid||54.80 x 800|
|Ask||54.83 x 1300|
|Day's Range||54.37 - 54.84|
|52 Week Range||45.58 - 59.00|
|Beta (5Y Monthly)||0.23|
|PE Ratio (TTM)||21.43|
|Earnings Date||Feb. 07, 2022 - Feb. 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||50.39|
Investors are optimistic about QIAGEN (QGEN) on strong third-quarter results and raised 2021 guidance.
QIAGEN's (QGEN) QuantiFERON SARS-CoV-2 assay enables a comprehensive assessment of immunity developed by COVID-19 vaccines.
Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.